BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 12626711)

  • 1. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
    Camarero N; Nadal A; Barrero MJ; Haro D; Marrero PF
    Nucleic Acids Res; 2003 Mar; 31(6):1693-703. PubMed ID: 12626711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex.
    Choi HS; Lee JH; Park JG; Lee YI
    Biochem Biophys Res Commun; 2002 Aug; 296(4):1005-12. PubMed ID: 12200149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
    Zhang Y; Dufau ML
    J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes.
    Schnur N; Seuter S; Katryniok C; Rådmark O; Steinhilber D
    Biochim Biophys Acta; 2007 Oct; 1771(10):1271-82. PubMed ID: 17894944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.
    Zelko IN; Folz RJ
    Free Radic Biol Med; 2004 Oct; 37(8):1256-71. PubMed ID: 15451065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the gamma-glutamyltransferase promoter 2 in the rat colon carcinoma cell line CC531 by histone deacetylase inhibitors is mediated through the Sp1 binding motif.
    Mikkelsen IM; Huseby NE; Visvikis A; Moens U
    Biochem Pharmacol; 2002 Jul; 64(2):307-15. PubMed ID: 12123752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
    Huang L; Sowa Y; Sakai T; Pardee AB
    Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
    Wu Y; Zhang X; Salmon M; Zehner ZE
    Genes Cells; 2007 Aug; 12(8):905-18. PubMed ID: 17663720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene.
    Ferguson M; Henry PA; Currie RA
    Nucleic Acids Res; 2003 Jun; 31(12):3123-33. PubMed ID: 12799440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoregulation of mouse histone deacetylase 1 expression.
    Schuettengruber B; Simboeck E; Khier H; Seiser C
    Mol Cell Biol; 2003 Oct; 23(19):6993-7004. PubMed ID: 12972616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
    Hou M; Wang X; Popov N; Zhang A; Zhao X; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu D
    Exp Cell Res; 2002 Mar; 274(1):25-34. PubMed ID: 11855854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression.
    Kwon HS; Huang B; Ho Jeoung N; Wu P; Steussy CN; Harris RA
    Biochim Biophys Acta; 2006; 1759(3-4):141-51. PubMed ID: 16757381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic control of HNF-4α in colon carcinoma cells affects MUC4 expression and malignancy.
    Algamas-Dimantov A; Yehuda-Shnaidman E; Peri I; Schwartz B
    Cell Oncol (Dordr); 2013 Apr; 36(2):155-67. PubMed ID: 23307400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor.
    Sowa Y; Orita T; Minamikawa-Hiranabe S; Mizuno T; Nomura H; Sakai T
    Cancer Res; 1999 Sep; 59(17):4266-70. PubMed ID: 10485470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
    Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
    Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S; Venkatasubbarao K; Li S; Freeman JW
    Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of histone acetylation on transcriptional regulation of manganese superoxide dismutase gene.
    Maehara K; Uekawa N; Isobe K
    Biochem Biophys Res Commun; 2002 Jul; 295(1):187-92. PubMed ID: 12083788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase.
    Gan Y; Shen YH; Wang J; Wang X; Utama B; Wang J; Wang XL
    J Biol Chem; 2005 Apr; 280(16):16467-75. PubMed ID: 15722551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells.
    Xiao H; Hasegawa T; Isobe K
    J Cell Biochem; 1999 Jun; 73(3):291-302. PubMed ID: 10321829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.